CPIX icon

Cumberland Pharmaceuticals

31 hedge funds and large institutions have $40.1M invested in Cumberland Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

less funds holding

Funds holding:

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $294K

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
$294K
Net Calls
Net Calls Change

Top Buyers

1 +$256K
2 +$169K
3 +$121K
4
Renaissance Technologies
Renaissance Technologies
New York
+$105K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$98.6K

Top Sellers

1 -$295K
2 -$244K
3 -$148K
4
BlackRock
BlackRock
New York
-$123K
5
NFA
Nationwide Fund Advisors
Ohio
-$27K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$9.62M
2
$6.7M
3
$6.59M
4
$2.78M
5
$2.43M
6
$2.35M
7
$2.1M
8
$1.94M
9
$1.91M
10
$933K
11
$646K
12
$399K
13
$360K
14
$183K
15
$150K
16
$146K
17
$145K
18
$123K
19
$97K
20
$81K
21
$77K
22
$75K
23
$74K
24
$62K
25
$38K